• FOXM1, ceRNA Networks, and ERα in Female Lung Adenocarcinoma

  2026-05-30

  This study systematically elucidates the role of FOXM1 in female lung adenocarcinoma (LUAD) by integrating genomic, transcriptomic, and cellular analyses. The discovery of a ceRNA network linking FOXM1 and estrogen receptor alpha (ERα) provides mechanistic insight into disease progression and highlights potential biomarkers for prognosis and targeted therapy.

• Nicotinamide Riboside Chloride in RGC and Neurodegeneration

  2026-05-29

  Nicotinamide Riboside Chloride (NIAGEN) is redefining metabolic and neurodegenerative disease modeling through precise NAD+ boosting and sirtuin modulation. By integrating NIAGEN into advanced stem cell–derived retinal ganglion cell workflows, researchers achieve superior reproducibility and functional outcomes, accelerating discovery in metabolic dysfunction research and neurodegenerative disease models.

• Halazone: Antimicrobial Sulfonamide Derivative in Modern Res

  2026-05-29

  Halazone's dual-action as an antimicrobial sulfonamide derivative enables rapid water disinfection and advanced neurophysiological assays. This guide delivers protocol-ready insights, troubleshooting strategies, and critical innovations that set APExBIO’s Halazone apart for cross-domain researchers.

• Norovirus Exploits NINJ1 for Selective Protein Secretion in

  2026-05-28

  Song et al. uncover how murine norovirus hijacks the host protein NINJ1 to enable selective secretion of its NS1 protein, revealing a distinct mechanism of unconventional protein export during viral infection. This work provides new insight into the interface between programmed cell death, innate immunity, and viral pathogenesis.

• Prestained Protein Marker (Triple Color): SDS-PAGE Precision

  2026-05-28

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) offers reliable, visible standards for protein sizing in SDS-PAGE and Western blot workflows. This triple-color molecular weight ladder enables precise size verification and transfer efficiency, as supported by peer-reviewed studies and manufacturer data.

• Applied Workflows with Carfilzomib (PR-171) in Cancer Resear

  2026-05-27

  Carfilzomib (PR-171) stands out as a potent, irreversible proteasome inhibitor that enables precise interrogation of proteasome-mediated proteolysis in cancer models. This article delivers actionable protocols, troubleshooting insights, and highlights translational advances from recent preclinical studies, positioning the compound as an essential tool in modern oncology research.

• Single-Base 5hmC Mapping Reveals Rice Drought Epigenetic Res

  2026-05-27

  Yan et al. deliver the first high-resolution map of 5-hydroxymethylcytosine (5hmC) in rice, uncovering its genomic context-dependent roles during drought adaptation. Their findings clarify how 5hmC dynamically regulates stress-related gene expression, providing a foundational resource for plant epigenetic research and crop resilience strategies.

• Dual-Action Inhibition of p38α MAPK: Structural Mechanisms a

  2026-05-26

  The reference study uncovers how certain kinase inhibitors can both block p38α MAPK activity and enhance its dephosphorylation by phosphatases, revealing a dual-action mechanism. This discovery provides new insights for designing next-generation p38 MAPK inhibitors with greater specificity and efficacy in inflammation research.

• Foretinib (GSK1363089): Data-Driven Solutions for Tumor Assa

  2026-05-26

  This article presents practical, scenario-based guidance for using Foretinib (GSK1363089) (SKU A2974) in cell viability, proliferation, and cytotoxicity assays. Drawing on validated literature and real-world lab workflows, it addresses common technical challenges and demonstrates how Foretinib enables reproducible, quantitative tumor cell growth inhibition and metastasis modeling. Direct links to protocols and product data are included for actionable next steps.

• 3X (DYKDDDDK) Peptide: Structural Precision in Protein Purif

  2026-05-25

  Discover how the 3X (DYKDDDDK) Peptide revolutionizes affinity purification and assay design through its unique structural and biochemical properties. This analysis explores advanced use cases and mechanistic insights for high-fidelity protein tagging and detection.

• Talabostat Mesylate (PT-100): Applied Protocols in Tumor Mic

  2026-05-25

  Talabostat mesylate (PT-100) unlocks targeted DPP4 and FAP inhibition for advanced modeling of the tumor microenvironment, T-cell immunity, and hematopoietic responses. This guide delivers actionable workflows, troubleshooting strategies, and translational insights that set it apart from standard reagent guides.

• AZD2461: Novel PARP Inhibitor Transforming Breast Cancer Ass

  2026-05-24

  AZD2461 stands out as a novel PARP inhibitor engineered to circumvent Pgp-mediated drug resistance and enhance the study of DNA repair pathways in advanced breast cancer models. This guide delivers actionable workflows, troubleshooting insights, and evidence-based protocol enhancements for translational and preclinical research.

• IWP-L6 (SKU B2305): Reliable Porcupine Inhibitor for Wnt Mod

  2026-05-23

  IWP-L6 (SKU B2305) is a highly potent, sub-nanomolar Porcupine inhibitor enabling robust, reproducible Wnt signaling modulation in diverse laboratory models. This article explores practical laboratory scenarios, highlighting how IWP-L6 from APExBIO addresses experimental challenges in cell viability and developmental assays.

• CLK2 Inhibition Overcomes Platinum Resistance in Ovarian Can

  2026-05-22

  This study demonstrates that Cdc2-like kinase 2 (CLK2) drives platinum resistance in ovarian cancer by phosphorylating BRCA1, thereby enhancing DNA repair and reducing chemotherapy efficacy. Targeting CLK2 represents a mechanistically validated approach to sensitizing ovarian tumors to platinum agents, offering a promising research direction for overcoming drug resistance in gynecologic oncology.

• Bobcat339: Reliable TET Inhibition for Epigenetics Research

  2026-05-22

  This article provides a scenario-driven exploration of Bobcat339 (SKU BA4643), a selective cytosine structure-based TET enzyme inhibitor, emphasizing its role in robust DNA methylation and gene transcription studies. Through real-world laboratory challenges, we demonstrate how Bobcat339 ensures experimental reproducibility and data integrity in advanced epigenetic regulatory mechanism research.

14893 records 1/993 page Next 12345 下5页 Last page